Stifel Nicolaus analyst Justin Keywood maintained a Buy rating on ZYUS Life Sciences (ZYUS – Research Report) today and set a price target of ...
Stifel Nicolaus analyst Annabel Samimy reiterated a Buy rating on Jazz Pharmaceuticals (JAZZ – Research Report) today. The company’s shares ...